103 related articles for article (PubMed ID: 10546783)
21. [Problems in the management of HIV infection in clinical practice. Patients still on dual therapy 8 years after the introduction of HAART].
Manfredi R
Recenti Prog Med; 2003 Nov; 94(11):506-7. PubMed ID: 14679919
[TBL] [Abstract][Full Text] [Related]
22. A prospective, randomized trial of structured treatment interruption for patients with chronic HIV type 1 infection.
Cardiello PG; Hassink E; Ananworanich J; Srasuebkul P; Samor T; Mahanontharit A; Ruxrungtham K; Hirschel B; Lange J; Phanuphak P; Cooper DA
Clin Infect Dis; 2005 Feb; 40(4):594-600. PubMed ID: 15712083
[TBL] [Abstract][Full Text] [Related]
23. The picture of future therapy.
Gazzard B
Int J Clin Pract Suppl; 1999 Jun; 103():45-8. PubMed ID: 10622045
[TBL] [Abstract][Full Text] [Related]
24. HIV antiviral drug guide 1998.
Whitfield L
Posit Aware; 1998; 9(1):28, 30-42. PubMed ID: 11364998
[TBL] [Abstract][Full Text] [Related]
25. Considerations in selecting protease inhibitor therapy.
Boyle BA; Elion RA; Moyle GJ; Cohen CJ
AIDS Rev; 2004; 6(4):218-25. PubMed ID: 15700620
[TBL] [Abstract][Full Text] [Related]
26. Strategies for protease inhibitor failure.
Proj Inf Perspect; 1997 Nov; (23):4-5. PubMed ID: 11365379
[TBL] [Abstract][Full Text] [Related]
27. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Guo JJ; Jang R; Louder A; Cluxton RJ
Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
[TBL] [Abstract][Full Text] [Related]
28. Risks and synergies from drug interactions.
Sahai J
AIDS; 1996 Nov; 10 Suppl 1():S21-5. PubMed ID: 8970672
[TBL] [Abstract][Full Text] [Related]
29. Dual protease inhibitor therapy in HIV-infected patients: pharmacologic rationale and clinical benefits.
Flexner C
Annu Rev Pharmacol Toxicol; 2000; 40():649-74. PubMed ID: 10836150
[TBL] [Abstract][Full Text] [Related]
30. Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patients.
Jiménez-Nácher I; Alvarez E; Morello J; Rodriguez-Nóvoa S; de Andrés S; Soriano V
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):457-77. PubMed ID: 21342079
[TBL] [Abstract][Full Text] [Related]
31. Review: mixing new cocktails: drug interactions in antiretroviral regimens.
Young B
AIDS Patient Care STDS; 2005 May; 19(5):286-97. PubMed ID: 15916491
[TBL] [Abstract][Full Text] [Related]
32. Protease inhibitor drug interactions.
Rose E; Romeyn M
BETA; 1997 Sep; ():29-38. PubMed ID: 11364696
[TBL] [Abstract][Full Text] [Related]
33. Significant interactions with new antiretrovirals and psychotropic drugs.
Tseng AL; Foisy MM
Ann Pharmacother; 1999 Apr; 33(4):461-73. PubMed ID: 10332538
[TBL] [Abstract][Full Text] [Related]
34. Managing potential drug-drug interactions between gastric acid-reducing agents and antiretroviral therapy: experience from a large HIV-positive cohort.
Lewis JM; Stott KE; Monnery D; Seden K; Beeching NJ; Chaponda M; Khoo S; Beadsworth MB
Int J STD AIDS; 2016 Feb; 27(2):105-9. PubMed ID: 25721922
[TBL] [Abstract][Full Text] [Related]
35. The protease inhibitors.
Tapp Alter K
Prim Care Update Ob Gyns; 2001 Mar; 8(2):59-64. PubMed ID: 11246029
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic considerations in critical care.
Reynolds JR
Crit Care Nurs Clin North Am; 1993 Jun; 5(2):227-35. PubMed ID: 8398031
[TBL] [Abstract][Full Text] [Related]
37. Alcohol use can result in enhanced drug metabolism in HIV pharmacotherapy.
Flexner CW; Cargill VA; Sinclair J; Kresina TF; Cheever L
AIDS Patient Care STDS; 2001 Feb; 15(2):57-8. PubMed ID: 11224929
[No Abstract] [Full Text] [Related]
38. [HIV protease inhibitors and interactions].
Justesen US; Brøsen K; Pedersen C
Ugeskr Laeger; 2000 Aug; 162(35):4677-81. PubMed ID: 10986900
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis treatment practices in the era of protease inhibitors: a provider survey.
Sundaram V; Driver CR; Munsiff SS
AIDS; 1999 Jan; 13(1):149-50. PubMed ID: 10207567
[No Abstract] [Full Text] [Related]
40. HIV topic update: protease inhibitor therapy and oral health care.
Porter SR; Scully C
Oral Dis; 1998 Sep; 4(3):159-63. PubMed ID: 9972165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
